HYPEBEAST(00150.HK)擬溢價配售653.3萬股 總籌692萬港元
格隆匯 3 月 25日丨HYPEBEAST(00150.HK)發佈公吿,2021年3月25日,公司與投資者就認購事項訂立投資協議。根據投資協議,公司有條件同意配發及發行6,533,397股股份,認購價為每股投資者股份1.05924港元。投資者根據投資協議應付的總代價為692.04萬港元,於投資協議日期相當於約1億日圓。
投資者股份佔公司已發行股份約0.32%及經認購事項擴大後公司已發行股份約0.32%。每股投資者股份1.05924港元的認購價較股份於投資協議日期收市價每股0.92港元溢價約15.13%。
認購事項所得款項總額合共約692.04萬港元,認購事項所得款項淨額約為662.04萬港元,而淨髮行價約為每股投資者股份1.013港元。公司擬將所得款項淨額用作與投資者進行戰略合作及執行業務計劃以及集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.